º¬Ðß²ÝÉçÇø

Skadden, Arps, Slate, Meagher & Flom is advising Tokyo-based Otsuka Pharmaceutical on its acquisition of clinical-stage biotechnology company

A look back at the blockbuster transactions of 2025 as we gallop into the Year of the Horse

Skadden and King & Spalding advised on MAM's USD1.72 billion DESRI investment agreement

DLA Piper appoints Ed Sheremeta as Tokyo real estate co-head, relocating from Hong Kong where he led the same practice

Skadden and Latham & Watkins are advising Otsuka Pharmaceutical on its USD1.12 billion acquisition of Jnana Therapeutics

Trial Holdings, a Japanese discount-store chain, completes global IPO on Tokyo Stock Exchange, raising USD258 million

Seven law firms seal Reliance-Viacom18-Disney USD8.5B joint venture deal